Ointment Recommendations for Non-Healing Ulcers
For non-healing ulcers, dressings should be selected primarily based on exudate control, comfort, and cost rather than specific types, with sucrose-octasulfate impregnated dressings considered for difficult-to-heal neuro-ischemic ulcers. 1
First-Line Approach Based on Ulcer Type
Standard Care for All Non-Healing Ulcers
- Sharp debridement is strongly recommended as the preferred method to remove slough, necrotic tissue, and surrounding callus 1
- Basic wound dressings should be selected based on:
- Amount of exudate
- Patient comfort
- Cost considerations 1
Specific Recommendations by Ulcer Type
For Non-Infected Neuro-Ischemic Diabetic Foot Ulcers
- Consider sucrose-octasulfate impregnated dressing as an adjunctive treatment when:
- Best standard care has been provided for at least 2 weeks
- Ulcer shows insufficient improvement
- This recommendation is supported by a large double-blind multinational RCT showing significant improvement in complete wound healing at 20 weeks 1
For Post-Surgical Diabetic Foot Wounds
- Consider negative pressure wound therapy to reduce wound size in addition to best standard care 1
For Non-Healing Ischemic Diabetic Foot Ulcers
- Consider hyperbaric oxygen therapy as an adjunctive treatment when standard care has failed 1
Treatments NOT Recommended
The following treatments are explicitly NOT recommended for non-healing ulcers based on current guidelines:
- Antimicrobial dressings: Do not use dressings containing antimicrobial agents with the sole aim of accelerating healing 1, 2
- Silver-based products: Not recommended for routine use in diabetic foot ulcers 2, 3
- Honey-based preparations: Not supported by evidence for routine use 1, 3
- Collagen or alginate dressings: Not recommended for wound healing of diabetic foot ulcers 1
- Topical phenytoin: Not recommended for wound healing in diabetic foot ulcers 1
- Herbal remedies: Do not use dressings or topical applications with herbal remedies 1
- Growth factors: Not recommended except in specific circumstances (becaplermin is only indicated for lower extremity diabetic neuropathic ulcers with adequate blood supply) 1, 4
- Autologous platelet gels: Not recommended as routine treatment 1
- Bioengineered skin products: Not recommended as routine treatment 1
- Physical environment altering agents: Do not use agents that alter the physical environment (electricity, magnetism, ultrasound, shockwaves) 1
Common Pitfalls to Avoid
Overreliance on antimicrobial dressings: Using antimicrobial dressings when there's no clinical infection can contribute to bacterial resistance without improving healing 2, 3
Neglecting underlying factors: Focusing only on topical treatments without addressing:
- Pressure relief/offloading
- Vascular status
- Glycemic control (in diabetic patients)
- Nutritional status
Delayed reassessment: If the ulcer does not decrease in size by approximately 30% after 10 weeks of treatment, continued treatment should be reassessed 4
Inappropriate debridement: Failing to recognize contraindications to sharp debridement such as severe ischemia or pain 1
Special Considerations
- For venous leg ulcers, evidence does not support routine use of silver-based products or honey-based preparations 3
- For pressure ulcers, there is limited evidence for any specific antimicrobial treatment, and some evidence suggests non-antimicrobial treatments may be more effective for wound healing 5
- Cost considerations are important - silver mesh dressings may be more cost-effective than silver sulfadiazine cream for pressure ulcers despite similar efficacy 6
By following these evidence-based recommendations and avoiding treatments not supported by current guidelines, clinicians can optimize the management of non-healing ulcers while minimizing unnecessary interventions.